Couverture de Diabetes Dialogues

Diabetes Dialogues

Diabetes Dialogues

De : Fortrea
Écouter gratuitement

3 mois pour 0,99 €/mois Offre valable jusqu'au 12 décembre 2025. 3 mois pour 0,99 €/mois, puis 9,95 €/mois. Offre soumise à conditions.J'en profite

À propos de ce contenu audio

 Diabetes Dialogues is a thought-provoking podcast series that dives deep into the science, challenges, and human stories shaping Type 1 diabetes research and care. Each episode brings together leading experts and advocates to explore breakthroughs in cell and gene therapies, the realities of clinical trial access, and the unique needs of both adult and pediatric populations. Through candid conversations, the series highlights how innovation and inclusion must go hand in hand to create a future without T1D, offering practical insights, emerging tools, and a shared vision for transforming patient outcomes. Hygiène et vie saine Maladie et pathologies physiques Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Diabetes Dialogues | Ep. 1 | Cracking the T1D cure code: From breakthrough science to breakthrough access

      Diabetes Dialogues | Ep. 1 | Cracking the T1D cure code: From breakthrough science to breakthrough access
      Nov 19 2025
      This episode brings together Dr. Friedrich Mittermayer and Dr. Esther Latres PhD, VP of Research, to discuss the exciting cures for T1D, and the challenges those clinical trials face. This podcast episode explores the urgent realities and untapped opportunities in adult T1D diagnosis and treatment. From the heartbreak of misdiagnosis to the promise of cell and gene therapies, we spotlight the real-world journeys that shape clinical trial access and outcomes. You’ll hear how delayed diagnoses push young adults beyond critical trial windows, why older patients are often overlooked, and how new tools—from EMR pilots to genetic rescores—are helping us find the right patients, faster. With insights from Breakthrough T1D, we rally around a shared vision: a world without T1D. Because the future of diabetes care isn’t just about innovation—it’s about inclusion.
      Afficher plus Afficher moins
      31 min
    • Diabetes Dialogues | Ep. 2 | The critical first 100 days for pediatric Type 1 diabetes patients

      Diabetes Dialogues | Ep. 2 | The critical first 100 days for pediatric Type 1 diabetes patients
      Nov 19 2025
      This episode brings together Mala Puri, Senior Medical Director at Fortrea and Dr. Sanjoy Dutta PhD Chief Scientific Officer to discuss the unique challenges faced by pediatric populations in Type 1 diabetes clinical trials. We explore the specific needs and barriers for children and their families, and the role of advocacy and research groups in supporting them. The conversation highlights practical examples of support programs and tools that can help pediatric patients participate in clinical trials, ensuring their voices are heard and their needs are met.
      Afficher plus Afficher moins
      25 min
    • Diabetes Dialogues | Ep. 3 | The human side of pediatric Type 1 diabetes

      Diabetes Dialogues | Ep. 3 | The human side of pediatric Type 1 diabetes
      Nov 19 2025
      In our previous episode, we explored the scientific foundation behind treating T1D as an autoimmune disease and the critical importance of those first 100 days after diagnosis. In this episode, we shift our focus to the human side of the equation. We'll tackle the real-world hurdles families face when navigating a new T1D diagnosis - from emotional overwhelm to information overload. More importantly, we'll discuss how we can design clinical trials that work for families, not against them, and explore the transformative power of true partnerships between sponsors, CROs, and patient advocacy groups.
      Afficher plus Afficher moins
      22 min
    Aucun commentaire pour le moment